
Pfizer plans to request approval for use of its COVID-19 vaccine in children under 12 soon. “It is a question of days, not weeks,” Pfizer chairman and CEO Albert Bourla told ABC News on Sunday when asked about when the company will submit vaccine data on children aged 5 to 11 to the U.S. Food… read on > read on >